Detection of Helicobacter pylori by enzyme-linked immunosorbent assay of thermophilic helicase-dependent isothermal DNA amplification by Gill, P. et al.
Available online at www.sciencedirect.com 
us Disease 59 (2007) 243 – 249 
www.elsevier.com/locate/diagmicrobio Diagnostic Microbiology and Infectio Detection of Helicobacter pylori by enzyme-linked immunosorbent assay

of thermophilic helicase-dependent isothermal DNA amplification
 
Pooria Gilla,⁎, Mohsen Aminib, Amir Ghaemic, Leily Shokouhizadehd,
 
Hossein Abdul-Tehranie, Ali Karamia, Armin Gilakf 
aResearch Center for Molecular Biology, Baqiyatallah Medical Sciences University, Tehran 16739-78964, Iran
 
bBaqiyatallah Hospital, Tehran 14359-15371, Iran
 
cFaculty of Medicine, Golestan University of Medical Sciences and Health Care, Gorgan, P.O. Box 619, Iran
 
dDepartment of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115-331, Iran
 
eDepartment of Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115-331, Iran
 
fISOCHEM, 53340 Meckenheim, Germany
 
Received 15 February 2007; accepted 8 May 2007 Abstract 
An enzyme-linked immunosorbent assay (ELISA) of thermophilic helicase-dependent isothermal DNA amplification (tHDA) was 
developed for detection of Helicobacter pylori. The primers targeting ureC were used for the amplification of bacterial DNA by the 
isothermal digoxigenin (DIG)-labeling tHDA process, resulting in the accumulation of DIG-labeled DNA amplicons. The amplicons were 
denatured using heat and then hybridized with a specific biotinylated DNA probe, which was noncovalently immobilized on streptavidin­
coated microtiter plate. The hybrids were colorimetrically detected by the addition of an anti-DIG antibody HRP conjugate and 2,2-azino-di­
(3-ethylbenzthiazolinsulfonate) substrate solution. Results obtained from the gastric biopsy samples showed 90% and 95.7% of sensitivity 
and specificity, respectively, in comparison with culture results, and 96.6% and 96.8% of sensitivity and specificity, respectively, in 
comparison with those of the histologic studies. This assay significantly reduces the time needed for the identification of H. pylori and has 
the potential to facilitate early detection of this gastrointestinal pathogen. 
© 2007 Elsevier Inc. All rights reserved. Keywords: tHDA-ELISA; Digoxigenin (DIG); Helicobacter pylori; ureC 1. Introduction 
Helicobacter pylori is a Gram-negative microaerophilic 
bacterium that infects human gastric epithelial cell 
surfaces. This bacterium causes chronic infection in a 
large proportion of the world's population and is 
associated with a number of different clinical conditions 
(Shahamat et al., 2004; Brooks et al., 2004). Accurate 
diagnosis is essential for the effective treatment and 
management of infections that are caused by this organism. ⁎ Corresponding author.
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doi:10.1016/j.diagmicrobio.2007.05.005 To overcome this problem, we have tested a variety of 
culture-independent methods for the detection of H. pylori 
in clinical samples (Brooks et al., 2004; Chanto Grettel et 
al., 2002; Chanfu et al., 1997). Polymerase chain reaction 
(PCR) also has been widely used to detect H. pylori from 
clinical specimens. However, it requires thermocycling to 
separate the two DNA strands (Lu et al., 1999; He et al., 
2002). A completely different approach is that of Kong et 
al. who came up with the idea of using a DNA helicase to 
separate the DNA strands rather than heat while working 
at New England Biolabs (Vincent et al., 2004). This new 
technique has been named thermophilic helicase-dependent 
isothermal DNA amplification (tHDA) and does not 
require thermocycling (An et al., 2005). In this study, we 
describe a relatively simple diagnostic method that detects 
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Fig. 1. DIG-labeling tHDA. The figure shows the DIG-labeling tHDA process. Step 1, the helicase unwind DNA duplexes. Step 2, the primers anneal to the 
ssDNA. Step 3, DNA polymerase extends the primers. One duplex is amplified to 2 duplexes. The dsDNAs are separated by helicase, and this chain reaction 
repeats itself. H. pylori in gastric biopsies called enzyme-linked immu­
nosorbent assay of tHDA (tHDA-ELISA) detection system 
(Figs. 1 and 2). 2. Materials and methods 
2.1. Bacterial culture and maintenance 
The H. pylori (ATCC 49503) strain was provided from 
the Department of Bacteriology, Faculty of Medical 
Sciences, Iran University of Medical Sciences, Tehran, 
Iran, preserved in LB broth medium and 20% sterile 
glycerol. The Escherichia coli (ATCC 11775) was used to 
evaluate the specificity of the tHDA reaction and grown in 
tryptic soy broth. 
2.2. Clinical biopsy samples 
One hundred twenty-four human gastric biopsy samples 
were obtained from patients and analyzed as they were 
received. Three sets of biopsy specimens from the antrum 
and the corpus of each patient's stomach were obtained, and 
each set was used for culture, histology, and tHDA-ELISA 
assay. The size of specimens was 3.5 to 5 mg in weight. 
These specimens were collected from patients seen in the 
Baqiyatallah Hospital, Tehran, Iran, in accordance with the 
ethical standards of the Helsinki Declaration of 1975 as 
reflected in the guidelines of the Medical Ethics Committee, 
Ministry of Health, I. R. Iran. The samples were not collected 
specifically for the current study. Histologic and micro-
biologic data were available for all samples tested. 2.3. Nucleic acids and DNA extraction 
Purified human tissue DNA and E. coli DNA were used 
to evaluate the impact of nonhomologous nucleic acids 
on the specificity of the tHDA reaction. The DNA from 
gastric biopsy specimens, human tissue, and bacterial 
standard media (E. coli ATCC 11775; H. pylori ATCC 
49503) were extracted using QIAGEN DNeasy tissue 
extraction kit (QIAGEN, Valencia, CA) according to the 
manufacturer instructions. 
2.4. Determinations of ureC gene copy number in H. pylori 
Genomic DNA from H. pylori (ATCC 49503) was 
extracted by the QIAGEN DNeasy tissue extraction kit and 
dissolved in 1 × TE buffer (10 mmol/L Tris and 1 mmol/L 
ethylenediaminetetraacetic acid [EDTA], pH 8.0). The 
absorbance of the DNA solution was measured at 260 nm 
3 times, and the mean value was recorded as the actual 
absorbance. The number of bacteria was calculated as the 
number of H. pylori per microliter = (concentration of DNA 
solution)/(mean mass of H. pylori genome). The mean mass 
of the H. pylori genome was calculated from the mean 
size of the genome, which was assumed to be 1.6 Mb (He 
et al., 2002). 
2.5. Primers and probe 
A primer pair was selected from published H. pylori ureC 
gene nucleic acid sequences (Genbank accession number 
M60398.1), synthesized by MWG Biotech, Germany. This 
pair of primers amplifies a 292-base pair (bp) of the target 
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Fig. 2. ELISA of DIG-labeled tHDA amplicons. Step 1, the single-stranded 
(denatured) DIG-labeled tHDA amplicon is associated with complement 
biotinylated capture probe. Step 2, the hybrid is transferred to streptavidin­
coated well to immobilize. Step 3, the ELISA DIG detection is performed to 
develop color. 
 
able 1 
ucleotide sequences of oligonucleotide primers and probe used in 
is study 
rimers/ Sequence Location 
robe 
PU F 5′-CTTTTAGGGGTGTTAGGGGT-3′ 1567–1588 
PU R 5′-DIG AAGCTTACTTTCTAACACTAACGC -3′ 1296–1319 
HPU P 5′-biotin CGATTGGGGATAAGTTTGTG-3′ 1433–1452 DNA that includes the species-specific region for oligonu­
cleotide probe to identify the H. pylori (Table 1). The reverse 
primer (HPU R) bears the digoxigenin (DIG)-11-dUTP at its 
5′ end. Biotin-modified probe (HPU P) corresponding to an 
internal region defined by the primers were synthesized 
by MWG Biotech and used for the detection of amplified 
target DNA. 2.6. tHDA process 
The reagents for tHDA were all from New England 
Biolabs. To set up a 25-μL DIG-labeling tHDA, we 
prepared 12.5 μL premix of DNA template and primers 
(2 μmol/L of each primer) in a 0.2-mL microcentrifuge tube 
in a sterile hood by combining 1.25 μL of 10× annealing 
buffer, 3.5 mmol/L MgSO4, and ddH2O to a volume of 
25 μL. The premix was incubated at 95 °C for 2 min and 
then 60 °C for 3 min using an incubator. An equal of 2× 
tHDA mix (200 μmol/L dNTPS, 3 mmol/L dATP, 10 U of 
Bst polymerase, 50 ng of Tte-UvrD helicase, ±200 ng Tte-
MutL, and ddH2O)—thawed and kept on ice—was added 
to the premix and gently mixed by pipetting followed by 
brief centrifugation. The reaction mixture was covered with 
a layer (50 μL) of inert oil (Sigma) to prevent evaporation 
during the reaction. The tube was incubated at 60 °C for 1 h. 
Negative control consisted of all of the same reagents but 
substituted for the target with an equal volume of ddH2O 
that contained no target nucleic acid. The amplification 
products were analyzed by agarose gel electrophoresis or by 
tHDA-ELISA detection system (Vincent et al., 2004; An 
et al., 2005). 
2.7. tHDA-ELISA detection system 
2.7.1. Coupling protocol for streptavidin-coated 
microtiter plate 
The Nunc Immobilizer™ streptavidin plate was washed 
with 3× 300-μL/well PBST buffer (phosphate-buffered 
saline containing 0.05% (vol/vol) TWEEN® 20, pH 7.2) 
without any incubation step. This was done to ensure 
improved readouts and a very low coefficient of variation 
(CV %). Biotinylated probe (HPU P) (0.1 μmol/L, 100 μL) 
diluted in PBST buffer was incubated in the plate at room 
temperature for 1 h with gentle agitation. After aspiration, 
the plate was washed 3 times with 300 μL of PBST to 
prepare for assay application (Koch et al., 2000). 
2.7.2. Colorimetric detection of the DIG-labeled amplicons 
Ten microliters of DIG-labeled tHDA product was heated 
5 min at 95 °C to denature and added to 100 μL of
hybridization solution (50 mmol/L sodium phosphate buffer, 
pH 7.0). The tHDA product (100 μL) was added to the 
oligoprobe-coated streptavidin microtiter plate and incu­
bated for 1 h at 37 °C with gentle shaking. Plates were 
washed 3 times with PBST buffer and incubated again for T
N
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DIG antibody HRP conjugate (Roche) diluted 1:100 in 
PBST buffer was added to each well, and microtiter plates 
were incubated for 30 min at room temperature. After 5 
washes with PBST buffer, 100 μL of 2,2-azino-di-(3­
ethylbenzthiazolinsulfonate) substrate (Roche) was added 
to each well and incubated at 37 °C for 15 min. Finally, the 
developed color was measured at 405 nm in a microtiter plate 
reader (Gill et al., 2006). 
2.8. Validation of the tHDA-ELISA 
2.8.1. Sensitivity determination 
For the evaluation of the sensitivity of the test, 10-fold 
serial dilutions of DNA from H. pylori (ATCC 49503) were 
prepared in TE buffer (10 mmol/L Tris, 1 mmol/L EDTA) for 
tHDA-ELISA procedure described above (Gill et al., 2006; 
Jean et al., 2002). 
2.8.2. Specificity determination 
For the evaluation of the specificity, nontarget nucleic 
acids, notably human genomic DNA and genomic E. coli 
DNA, were added, alone or in the presence of H. pylori 
DNA, and analyzed by the tHDA-ELISA detection system 
(Gill et al., 2006; Jean et al., 2002). 3. Results 
3.1. Specificity evaluation of the tHDA process 
The analyses of the tHDA products from H. pylori 
(ATCC 49503) by agarose gel electrophoresis show a unique 
band corresponding to the expected size of 292 bp (Fig. 3). Fig. 3. Analysis of primer specificity of tHDA process. Lane M, 100 bp of 
molecular marker (Fermentas). Lane 1, no band of tHDA product on 
negative control. Lane 2, no band of tHDA product on E. coli (ATCC 
11775). Lane 3, no band of tHDA product on human DNA. Lane 4, 292 bp 
of tHDA product on H. pylori (ATCC 49503). No band was observed with the negative control, with the E. 
coli DNA and with the human genomic DNA early 
templates. The results confirmed the effectiveness of the 
tHDA system developed and the specificity of the selected 
primer pair for the amplification of the target region in 
ureC DNA. 
3.2. Detection of DIG-labeled tHDA amplicons by DIG 
detection ELISA 
As shown in Fig. 4, the efficiency of the tHDA-ELISA 
was confirmed by analyzing 2-fold serial dilutions of DIG-
labeled tHDA amplicons of ureC DNA from H. pylori. 
3.3. Specificity evaluation of the tHDA-ELISA 
detection system 
The specificity of the tHDA-ELISA detection system was 
confirmed by the analysis of nontarget nucleic acids obtained 
from E. coli DNA and human genomic DNA. The results 
showed no detection of any target nucleic acid (Fig. 5). 
3.4. Sensitivity determination of the tHDA-ELISA 
detection system 
The analytical sensitivity of the tHDA-ELISA assay was 
determined by testing serial dilutions of H. pylori (ATCC 
49503) concentration with a detection limit of 10 copies of 
H. pylori ureC gene (Fig. 6). From the results, the cutoff 
value of the test was calculated 0.3 ± 0.1 according to the 
optical density in 405 nm for this detection system. 
3.5. Clinical performance of assay 
The clinical performance of the tHDA-ELISA assay was 
determined by comparing the tHDA-ELISA results with 
those of culture and histologic studies. Included in the study 
were 124 gastric biopsy samples. The overall results 
presented in Table 2 indicate that tHDA-ELISA has a 
sensitivity of 90% and specificity of 95.7% in comparison 
with those of the culture, and sensitivity of 96.6% and 
specificity of 96.8% in comparison with those of the 
histologic studies. 4. Discussion 
The detection of H. pylori is critical because of the high 
prevalence of this species, its worldwide distribution, and the 
large number of individuals carrying this organism (Chanto 
Grettel et al., 2002; Dale et al., 1998; Feldman, 2001; 
Suerbaum and Michetti, 2002). Molecular methods, in 
particular, PCR, have the potential to detect more cases of 
infection because of their greater sensitivity but are 
technically demanding (Ho and Windsor, 2000). Despite its 
widespread appeal, the need for temperature cycling in PCR 
limits its portability because of the significant energy used in 
such sensitive instrumentation. As a result, several isother­
mal amplification methods have been developed (Walker 
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Fig. 4. DIG detection ELISA and gel electrophoresis of 2-fold serial dilutions of DIG-labeled tHDA products. tHDA was performed in the presence of 103 
copies of ureC gene on H. pylori (ATCC 49503), and then DIG-labeled tHDA product was 2 fold serially diluted before DIG detection ELISA system (series 
1). NSB, DIG detection ELISA of 2-fold serial dilutions of DIG-labeled tHDA product of negative control (series 2). The plotted results are the averages of 
triplication analysis. et al., 1992; Dean et al., 2001; Compton, 1991; Notomi et al., 
2000; Wharam et al., 2001; Kurn et al., 2005). Recently, a 
true isothermal DNA amplification technology that incorpo-Fig. 5. Specificity of the tHDA-ELISA detection system. tHDA-ELISA was 
performed with nontarget nucleic acids such as total E. coli DNA and human 
DNA. tHDA-ELISA was performed on DNA of H. pylori (ATCC 49503) as 
a positive control. DIG detection ELISA was performed on ddH2O as  a  
negative control. rates a helicase enzyme into the reaction scheme was 
reported (Vincent et al., 2004). Helicase-dependent ampli­
fication exploits the unwinding activity of a helicase to ig. 6. Sensitivity of the tHDA-ELISA detection system for detection of H. 
ylori ureC gene. Ten-fold serial dilutions of H. pylori were prepared and 
sed for DNA extraction and DIG-labeling tHDA by the above protocols. 
hen 10 μL of the tHDA products was used in DIG detection tHDA-ELISA 
stem. Each dilution was analyzed in duplicate. F
p
u
T
sy
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Table 2 
Comparison of culture results and histologic studies with those of the tHDA-ELISA assay 
Test and 
result 
No. of culture results 
Positive Negative 
Sensitivity 
(%) 
Specificity 
(%) 
No. of histologic studies 
Positive Negative 
Sensitivity 
(%) 
Specificity 
(%) 
tHDA-ELISA 
Positive 
Negative 
27 
3 
4 
90 
90.0 95.7 29 
1 
3 
91 
96.6 96.8 separate duplex DNA targets during in vitro DNA 
amplification, eliminating the need for thermocycling (An 
et al., 2005). The present study is related to the detection of 
H. pylori in human gastric biopsies using a simple and rapid 
molecular technique called tHDA-ELISA detection system. 
The assay procedure is composed entirely of transfers, 
additions, and incubation, and is not technically demanding. 
However, to avoid potential carryover contamination, 
careful adherence to the protocol, including bleach decon­
tamination of reaction tubes and work surfaces, is required. 
Results obtained by testing dilutions of H. pylori detected 
10 copies of the ureC gene. However, Kong et al. have 
reported 500 copies of target gene in their study for gel 
electrophoresis tHDA end-point detection (An et al., 2005). 
The increased sensitivity seen here may be because the 
detection step is performed with ELISA of DIG-labeled 
tHDA amplicons. 
The clinical sensitivity was 90.0% compared with 98.3% 
of the culture (Shahamat et al., 2004). This compares with 
the reported sensitivities for PCR, which range from 34% to 
100% (Brooks et al., 2004; Chanto Grettel et al., 2002; 
Foxall et al., 1992; Tomb et al., 1997; Valentine et al., 1991). 
In a study of this type, the clinical sensitivity of a test is 
dependent on 4 major factors: 1) the analytical sensitivity of 
the assay, 2) the sensitivity of the standard (culture 
technique), 3) the distribution of positive specimens, from 
low positive to high positive, included in the study, and 
4) the effects of sample heterogeneity, especially in samples 
with low-positive results. In conclusion, the combination of 
tHDA with the microplate hybridization system offers 
several advantages (including optimal sensitivity and 
specificity) over other molecular techniques. This assay is 
simple and rapid (4 h) to perform, and allows the analysis of 
several samples simultaneously. On the other hand, the 
system is cost-effective because it does not require an 
expensive thermocycler and the reagents can be obtained 
with the nearly same budget needed for the PCR from New 
England Biolabs or Biohelix Corporation. 
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